VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade
John S. Rudge(MedStar Washington Hospital Center), George D. Yancopoulos(Regeneron (United States)), Gavin Thurston(Regeneron (United States)), Raymond Leidich(Regeneron (United States)), Donna Hylton(Regeneron (United States)), Michelle Russell(Regeneron (United States)), Nicholas Papadopoulos(Regeneron (United States)), Erica Pyles(Regeneron (United States)), Jocelyn Holash(Regeneron (United States)), Neil Stahl(Regeneron (United States)), Stanley J. Wiegand(Regeneron (United States)), Al Torri(Regeneron (United States)), Shelly Jiang(Regeneron (United States))
Cited by 203
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k
Evinacumab for Homozygous Familial Hypercholesterolemia
|New England Journal of Medicine|2020|763